Search results for: rn

November 21st, 2007

So… what’s with the ear horn?

Since I started blogging in June, I’ve been learning a lot about the art of conversation. While I’ve been trying to find my voice to offer perspective on stories, I’m also hearing a lot from people who either agree with or disagree with me. I often feel like I’ve just crashed a cocktail party — as I barge into some fascinating conversations that have been going on for a while without me, I sometimes find that I not only have something to add but can also leave with some useful nugget from that conversation to use elsewhere.

I’m not alone — and talking to my historian colleague Margaret, I get the impression that this really isn’t all that new. When Johnson & Johnson started back in 1886, conversations occurred all the time between the company, its customers and the community. We’ve both found that blogs can be a way for us to go back to the future to reengage with people and hear what we’ve been missing. And I’m delighted to have been joined by some of my colleagues at Johnson & Johnson in more recent postings on JNJBTW.

Alas. Though we’re trying, we still have to get better at listening.

Read More

September 25th, 2007

Sharing the Learning Curve

I have only been a part of Johnson & Johnson since the beginning of the year, and so I get questions from my friends and family all the time about what it is like now to be working at Johnson & Johnson, “the baby company.” This question is usually followed by a request for baby lotions, beauty products or Band-Aid Brand adhesive bandages.

It can be a steep learning curve coming into Johnson & Johnson and getting up to speed on its many businesses, but as I learn things I hope to share some of my observations with you. I want to provide a voice on JNJBTW that brings a bit of an “outsider’s” perspective.

Johnson & Johnson is no different than most companies in the fact it faces sizable business challenges every day. For example, as a health care company with a pharmaceuticals business, we have to deal with how to replace significant revenues from drugs that will be going off patent and how to handle unprecedented reimbursement challenges for drugs like erythropoiesis-stimulating agents (speaking of my learning curve…).

There is a healthy curiosity and a natural skepticism in the marketplace about how companies, including Johnson & Johnson, can overcome such challenges.

Read More

June 24th, 2015

Sports Injury Prevention Programs Help Keep Kids Moving

With the school year coming to an end, more of our days are spent out on the soccer field or in right field. Unfortunately, with an increase in sports activity parents worry more about their children’s risk of sports injury. More than 2.6 million children and adolescents are treated in the emergency department each year for sports and recreation-related injuries.[1] In fact, children aged 15-17 experience the highest emergency room visits for sports injuries, many of which are preventable.[2] These injuries are not limited to contact sports; in fact as many as 70 percent of anterior cruciate ligament (ACL) knee injuries involve little or no contact with the other player.[3]

DS SafeKids

DePuy Synthes Mitek Sports Medicine has worked with sports medicine orthopedic practices and Safe Kids Worldwide™ for nearly a decade to host educational clinics throughout the country to keep kids moving. This program, called PASSION2PLAY™, educates parents, coaches and young athletes about the importance of preventing sports-related injuries through sponsored educational clinics featuring clinical experts as well as tips for proper warm-up routines, injury prevention strategies and when it might be necessary to seek appropriate medical attention for injuries.

The latest PASSION2PLAY event with Safe Kids Worldwide featured professional football player Rueben Randle, who joined local teens in Waldwick, New Jersey and shared his experience with sports injury in the NFL and the importance of stretching and warming up.

Read More

June 16th, 2015

Cancer and Clots: An Unrecognized and Under-Researched Patient Burden

By Paul Burton, MD, PhD, Vice President, Medical Affairs, Janssen

More than one-third of all men and women in the United States will be diagnosed with cancer over the course of their lives. Living with cancer, the treatments and their side effects are significant burdens on their own. What many people with cancer often don’t realize is they are up to five times more likely to develop life-threatening blood clots than people the same age without cancer. These clots can occur deep in the veins in many parts of the body and sometimes travel to the lungs, a condition called venous thromboembolism (VTE). This risk is even more pronounced when patients with cancer undergo chemotherapy.

Blood clots are the second-leading cause of death in patients with cancer. We need a better understanding of how we can treat and prevent them, particularly for a large number of the one million patients who are treating their cancer outside the hospital.

That’s why the Janssen Pharmaceutical Companies of Johnson & Johnson, in conjunction with Bayer HealthCare, are furthering our commitment to addressing the most important unmet medical needs of our time by initiating a new research program: CALLISTO. CALLISTO is aimed at generating new evidence in the prevention and treatment of blood clots in patients with a wide range of cancer types.

Read More

June 5th, 2015

Domestic Violence: A Human Health Crisis

By Dr. Husseini Manji, Global Head, Neuroscience, Janssen Research & Development and Dr. Danielle Coppola, Senior Director, Compound Development Team, and Clinical Leader, Janssen Research & Development

Domestic Violence: A Human Health Crisis

When we talk about a public health care crisis, conversations often turn to serious illnesses like diabetes, cancer, and cardiovascular disease. But the growing body of evidence shows that domestic violence can be as devastating as the world’s most complex diseases.

The Centers for Disease Control and Prevention (CDC) lists domestic violence— sometimes referred to as “intimate partner violence” or IPV—as a “serious, preventable public health problem.” Domestic violence affects individuals and families and places a heavy burden on communities, law enforcement, and health care systems. In the United States alone:

  • Twenty-four people per minute are victims of physical violence by an intimate partner.1 In one study, 53 percent of men and 69 percent of women said they had experienced some form of intimate partner violence before the age of 25.2
  • Women ages 16 to 24 are four times more likely than the general population to be victims of partner violence.3
  • Up to 70 percent of men who abuse their partners also sexually or physically abuse their children.4
  • Medical costs associated with intimate partner violence are estimated at $5.8 billion each year.

Read More

June 4th, 2015

Leading the Way in Orthopaedics Innovation

By Martin Fitchet, M.D., Global Head, Research & Development, DePuy Synthes Companies of Johnson & Johnson

Martin Fitchett

On Thursday, a groundbreaking new era in orthopaedic innovation was launched for the DePuy Synthes Companies of Johnson & Johnson. I had the privilege to join my colleagues and distinguished guests, including Dr Mark Treherne, Chief Executive, UK Trade & Investment for the Life Sciences Organization, for the official opening of the newly redeveloped DePuy Synthes Beeston campus, based in Leeds, United Kingdom (UK). Our Beeston site has undergone extensive redevelopment to establish a leading global facility for Research & Development (R&D) in the field of orthopaedics.

I am incredibly proud to be a part of this exciting new chapter for DePuy Synthes. Our company is the largest, most comprehensive orthopaedics and neuro business that offers an unparalleled breadth of innovations to help advance the health and well-being of people around the world.

When it comes to advancements in orthopaedics, innovation is critical. By expanding our capabilities through state-of-the-art facilities at the Beeston campus, our R&D team will be better able to foster innovation, creating solutions to meet the needs of our patients and customers, while nurturing local talent and providing a significant contribution to the local economy.

Read More

June 2nd, 2015

Now is the Time for Personal Care Products Safety Reform

By Jeff B. Smith, President, U.S. Skincare, Johnson & Johnson Family of Consumer Companies

Jeff B. Smith

It’s been more than 70 years since the United States last updated our laws regulating personal care products, which include products from baby shampoo to anti-wrinkle creams. We think you’ll agree that public health and safety laws passed in the late 1930s deserve to at least be revisited for accuracy and relevancy. It’s for that reason the Johnson & Johnson Family of Consumer Companies supports modernizing a law that will enhance the U.S. Food and Drug Administration’s (FDA) authority to regulate personal care products, helping to bring peace of mind to consumers across the United States.

The Johnson & Johnson Family of Consumer Companies supports the Personal Care Products Safety Act sponsored by Senators Diane Feinstein (D-CA) and Susan Collins (R-ME). We welcome the opportunity to work with Congress and the U.S. FDA to better serve consumers and we thank Senators Feinstein and Collins for their bipartisan leadership on this important issue.

For more on our position on the Personal Care Products Safety Act, see here.

In short, Johnson & Johnson is supporting legislation that willrequire the registration of manufacturing facilities for personal care products;

  • require industry to report adverse events to FDA;
  • standardize Good Manufacturing Practices (GMPs) for cosmetics and personal care products;
  • and grant the FDA mandatory recall authority.

Read More

May 27th, 2015

Johnson & Johnson Study Shows 45.5 years as the “Tipping Point” for Adult Health

Prevention and Health Maintenance are Key

By Dr. Jennifer Turgiss, DrPH, Vice President of Behavior Science and Analytics at Johnson & Johnson Health and Wellness Solutions, Inc.

What do you think of when you hear the term “over the hill?” The American Heritage Dictionary of Idioms[1] defines it as “past one’s prime” and the term is used to describe the decline caused by aging. There is actually a science to studying where the pinnacle of that proverbial “hill” is—at what point do things start going downhill from a health perspective and most importantly, what can we do to postpone that trip “over the hill?”

At Johnson & Johnson Health & Wellness Solutions, Inc., our focus is on developing holistic health solutions that treat the whole individual. Behavioral scientists from our organization were part of a team that recently published a study in the journal PLOS ONE that has far-reaching implications for health maintenance and disease prevention in middle age. [Read the press release here.]

AvalancheThe research team tested a study sample of 55,550 adults enrolled in a healthcare program over a three -year period to test the hypothesis that there is a breakpoint during the adult life that separates a period of relatively good health with a period of increasing declining health.

Read More

May 15th, 2015

Johnson & Johnson Employees Honored by Operation Smile

Would you ever think that polishing shoes could make a life-changing difference for someone you’ve never met? Or playing chess? Or selling ice cream?

Johnson & Johnson employees have changed more than 100,000 children’s lives doing things just like those to raise money to benefit Operation Smile. And last night I had the tremendous privilege of representing our employees to accept the first-ever Global Impact Award from Operation Smile. This honor recognizes the many hours and boundless passion that our employees have brought to fundraising activities, volunteer projects and other initiatives to benefit Operation Smile and the children it serves.

In my 30+ years with Johnson & Johnson, I have never seen our employees so engaged in our shared effort to serve patients all over the world. Fulfilling our Johnson & Johnson Credo is a mission we all hold near and dear to our hearts. By supporting Operation Smile in its mission to provide safe surgical solutions to children born with cleft lip or cleft palate, they bring to life our Credo responsibility to our patients.

Every three minutes, a child enters the world with this deformity. Without treatment, these children may not get enough to eat. They often have speech problems.

Read More

May 14th, 2015

Q&A with J&J Human Performance Institute’s Jennifer Lea

Editor’s Note: Johnson & Johnson is a proud sponsor of the Know Your Value tour, a nationwide effort focused on empowering women to express their worth in business and in life. Part of the tour includes the Grow Your Value contest hosted by best-selling author and Morning Joe co-anchor Mika Brzezinski. At the Center of the Contest is the Johnson & Johnson Human Performance Institute, which works with the finalists to help transform their lives through coaching, networking and support. J&J recently spoke with HPI Performance Coach Jennifer Lea about coaching women to recognize their value and the important role of energy management.

Jennifer Lea Joanna Schwartz Grow Your Value

Jennifer Lea (right) with Joanna Schwartz, winner of the Grow Your Value contest in Philadelphia.

Q: How is the Johnson & Johnson Human Performance Institute playing a role in teaching women to know their value?

A: The Johnson & Johnson Human Performance Institute is the pioneer in training business leaders to achieve sustained high performance by expanding and managing their energy. We’ve developed life-changing programs that take a holistic, mind and body approach to help individuals achieve their best at work and at home by making fundamental life changes. Our renowned Corporate Athlete Program helps people become physically energized, emotionally connected, mentally focused, and completely aligned with achieving their personal mission so they can achieve their personal best both at work and at home.

Read More